Skip to main content
Premium Trial:

Request an Annual Quote

Sequencing Startup Omniome Closes $60M Series C Financing

NEW YORK – Omniome announced Thursday that it has raised $60 million in Series C financing, led by Madrone Capital Partners.

The San Diego-based firm said in a statement that it would use the funds to "accelerate late-stage product development and launch planning," continue optimizing its "scar-free" sequencing biochemistry, and further develop its instrument. It will also expand its workforce, especially in manufacturing, engineering, development, customer support, and commercial operations.

"The goal and vision have always been to develop a disruptive sequencing technology taking into account accuracy, speed, throughput, and cost," Omniome Executive Chairman Ken Song said in a statement. "The team's success in advancing product development across these dimensions has attracted considerable interest from top-tier investors."

The San Diego-based DNA sequencing firm has now raised at least $145 million, it said in a statement, with $60 million from its Series B financing round in 2018.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.